Conceptio › Archive › HAL (France)
HAL (France)open access

Ivermectin for Critically and Noncritically Ill Hospitalized Patients With COVID-19: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP)

Madiha Hashmi et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
antiviralintensive-careivermectin
Intensive care, Pneumonia wwwccmjournalorg, COVID-19, Adaptive platform trial, Adaptive platform trial antiviral COVID-19 intensive care ivermectin pneumonia wwwccmjournalorg, Antiviral, 0, Ivermectin
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 274409
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.